TowerJazz and USAF/AFRL Kick-Off Five-Year ROIC Foundry Improvement and Sustainability Program

TowerJazz has announced the award and program kick-off of a Technology Investment Agreement (TIA) with the United States Air Force/Air Force Research Laboratory (USAF/AFRL) of the Wright-Paterson Air Force Base.

The Defense Production Act Title III program is a five-year multi-million dollar Large Format Read Out Integrated Circuit (ROIC) Foundry Improvement and Sustainability program focused on continued technology and manufacturing leadership and improvements for TowerJazz’s Newport Beach, CA wafer fabrication facility in support of TowerJazz's overall aerospace and defense offering and customers. TowerJazz is a leading manufacturer of state-of-the art ROICs which are key elements in many commercial and military detectors, sensors, and imaging systems spanning air, land, sea and space. This award will enhance TowerJazz's ability to support production requirements of increasingly complex future ROIC designs.

TowerJazz continues to expand CMOS production for ROICs used in imaging arrays in both un-cooled and cooled applications in support of increased demand spanning 0.5-micron to 0.18-micron technology nodes. The five year program with the Title III Office will focus on the most advanced 0.18-micron CMOS process based large-die, stitched ROICs. In the 0.18-micron node, TowerJazz is making available to its ROIC customers its 1.8V/3.3V or 1.8V/5V dual gate oxide processes in a variety of substrate options such as bulk, epi and thick film SOI and with a wide range of desirable mixed-signal features from its commercial technology including high density linear MIM capacitors, precision resistors with triple well isolation and bipolar elements. TowerJazz also provides cryogenic models for its devices ensuring a high degree of confidence in the first time success of cooled ROIC designs.

TowerJazz operates a full on-shore facility with ITAR mask suppliers continuing a tradition started over 20 years ago when this facility was the primary semiconductor manufacturing site for Rockwell International. In addition to supporting the manufacture of ITAR designs, TowerJazz is now also able to offer Trusted Solutions through Jazz Semiconductor Trusted Foundry.

“TowerJazz is extremely excited to have this opportunity to partner with Wright-Patterson AFB in support of the Air Force’s Large Die ROIC foundry improvement and sustainability program. This program will leverage past and ongoing accomplishments at TowerJazz in support of on-shore fabrication critical to our National Defense and assist in enabling the next generation of essential Aerospace and Defense applications,” said Mike Scott, Director, USA Aerospace and Defense Division, TowerJazz.

About TowerJazz

Tower Semiconductor Ltd. (NASDAQ:TSEM, TASE:TSEM), its fully owned U.S. subsidiary Jazz Semiconductor, Inc. and its fully owned Japanese subsidiary TowerJazz Japan, Ltd., operate collectively under the brand name TowerJazz, the global specialty foundry leader. TowerJazz manufactures integrated circuits, offering a broad range of customizable process technologies including: SiGe, BiCMOS, Mixed-Signal/CMOS, RFCMOS, CMOS Image Sensor, Power Management (BCD), and MEMS capabilities. TowerJazz also provides a world-class design enablement platform that enables a quick and accurate design cycle. In addition, TowerJazz provides (TOPS) Transfer Optimization and development Process Services to IDMs and fabless companies that need to expand capacity. TowerJazz offers multi-fab sourcing with two manufacturing facilities in Israel, one in the U.S., and one in Japan.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.